Trodelvy 180mg (Sacituzumab govitecan-hziy Vials) 180mg

Trodelvy 180mg (sacituzumab govitecan-hziy) is an injectable therapy for certain cancers. This prescription medication targets specific cancer cells to help reduce disease progression. Store between 2-8°C and use as directed by a healthcare provider. Always consult a medical professional before starting treatment.

Strength

180mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Gilead Sciences

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trodelvy 180mg is used to treat metastatic triple-negative breast cancer and certain other advanced cancers. It works by targeting cancer cells with a specific protein marker. Patients often use it when other treatments have not been effective. This medication is designed for adults who meet specific medical criteria.

Side Effects

After receiving Trodelvy 180mg, patients may experience changes in energy levels or appetite. Some report mild to moderate side effects like nausea or fatigue, which can vary by individual. These effects are typically monitored by a healthcare team during treatment. Always report any unusual symptoms promptly.

Precautions & Warnings

Trodelvy 180mg should be handled with care and stored at 2-8°C to maintain potency. Avoid exposure to extreme temperatures or direct sunlight. Patients should inform their doctor about all current medications and health conditions before starting treatment. Regular medical supervision is required during therapy.

Avoid Interactions

Trodelvy 180mg may interact with other medications, including certain chemotherapy drugs or blood thinners. Alcohol and herbal supplements could also affect how this treatment works. Always disclose all medications to your healthcare provider to avoid potential interactions. Some interactions may require dose adjustments.

Frequently Asked Questions

Trodelvy 180mg is used to treat metastatic triple-negative breast cancer and certain other advanced cancers in adults.

Trodelvy 180mg is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common side effects may include nausea, fatigue, or changes in appetite, which should be reported to a doctor.

Trodelvy 180mg requires a prescription and should only be obtained through licensed pharmacies or healthcare providers.

Store Trodelvy 180mg vials between 2-8°C and protect from light until time of use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.